SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fudin, J.
Right arrow Articles by Coleman, J.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Chronic Pain Management with Opioids in Patients with Past or Current Substance Abuse Problems

Jeffrey Fudin, BS, PharmD, RPh, DAAPM

Interdisciplinary Pain Management and Primary Care Clinics (VAMC), Albany College of Pharmacy, and American Pharmaceutical Care Pain Consultants, fudinj{at}acp.edu

Deborah J. Levasseur, PhD

Interdisciplinary Pain Management and Primary Care Clinics (VAMC)

Steven D. Passik, PhD

Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentuck

Kenneth L. Kirsh, PhD

Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentuck

John Coleman, MS, MA

Drug Enforcement Administration: Law Enforcement and Office of Diversion Control

Among patients who present to medical providers with chronic pain complaints, there is an elevated prevalence of illicit substance use and prescription misuse. For those with legitimate pain, this predicament potentiates the risk of being medically underserved or undertreated. Complicating factors include a lack of specificity and sensitivity to the issue of defining substance abuse or misuse in the health care setting. Irrespective of whether patients have histories of addiction, problematic behavior manifests during the course of chronic pain therapy, making a conceptualization of the nature and function of this behavior difficult. The objective of this article is to highlight known confounds in the assessment of "normal" pain-related vs. substance abuse behavior. Our aim is to offer important points to consider, a set of systematic guidelines to follow, and an armamentarium of essential tools to facilitate contingency management planning in the context of treating chronic pain with controlled substances.

Key Words: Chronic pain management • substance abuse • pseudoaddiction • opioid therapy • controlled substances.

Journal of Pharmacy Practice, Vol. 16, No. 4, 291-308 (2003)
DOI: 10.1177/0897190003258507


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement